Hormonal therapy

Some breast cancers are caused due to the hormones in blood. It is a form of systemic therapy it not only reaches the cancer cells present in breast also reaches cancer cells all over the body. Hormonal therapy is recommended for women with hormone receptor-positive breast cancers, it is not useful for the women who are suffering with hormone receptor-negative breast cancer.

Hormonal therapy is often used as adjuvant therapy to reduce the risk of cancer coming back. Sometimes this therapy is started as neoadjuvant therapy. The drugs that stop estrogen from affecting breast cancer cells are,

  • ER-positive cancers
  • PR-positive cancers
  • Adjuvant therapy
  • Neo-adjuvant therapy
  • Breast cancer hormone therapy
  • Prostate cancer hormone therapy
  • Womb cancer hormone therapy

Related Conference of Hormonal therapy

July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
October 24-25, 2025

25th World Congress on Cancer and Diagnostics

Zurich, Switzerland
November 20-21, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain
December 08-09, 2025

13th Euro Breast Cancer and Therapeutics

Aix-en-Provence, France
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 23-24, 2026

16th World Congress on Breast Cancer Research & Therapies

Aix-en-Provence, France

Hormonal therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in